Depletion of alveolar macrophages attenuates hypoxic pulmonary hypertension but not hypoxia-induced increase in serum concentration of MCP-1
Exposure to hypoxia, leading to hypoxic pulmonary hypertension (HPH), is associated with activation of alveolar macrophages (AM). However, it remains unclear how AM participate in this process. There are studies which imply that the AM product monocyte chemoattractant protein-1 (MCP-1) plays an important role. Thus we tested: 1. if the selective elimination of AM attenuates HPH in rats, 2. the correlation of MCP-1 plasmatic concentrations with the presence and absence of AM during exposure to hypoxia, 3. the direct influence of hypoxia on MCP-1 production in isolated AM. We found that experimental depletion of AM attenuated the chronic hypoxia-induced increase in mean pulmonary arterial pressure, but did not affect the serum MCP-1 concentrations. Furthermore, the MCP-1 production by AM in vitro was unaffected by hypoxia. Thus we conclude that AM play a significant role in the mechanism of HPH, but MCP-1 release from these cells is most likely not involved in this process. The increase of MCP-1 accompanying the development of HPH probably originates from other sources than AM.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2016 |
---|---|
Erschienen: |
2016 |
Enthalten in: |
Zur Gesamtaufnahme - volume:65 |
---|---|
Enthalten in: |
Physiological research - 65(2016), 5 vom: 23. Nov., Seite 763-768 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Žaloudíková, M [VerfasserIn] |
---|
Themen: |
0813BZ6866 |
---|
Anmerkungen: |
Date Completed 03.04.2017 Date Revised 28.02.2020 published: Print-Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM262533049 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM262533049 | ||
003 | DE-627 | ||
005 | 20231224201948.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2016 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0875.xml |
035 | |a (DE-627)NLM262533049 | ||
035 | |a (NLM)27429111 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Žaloudíková, M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Depletion of alveolar macrophages attenuates hypoxic pulmonary hypertension but not hypoxia-induced increase in serum concentration of MCP-1 |
264 | 1 | |c 2016 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 03.04.2017 | ||
500 | |a Date Revised 28.02.2020 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Exposure to hypoxia, leading to hypoxic pulmonary hypertension (HPH), is associated with activation of alveolar macrophages (AM). However, it remains unclear how AM participate in this process. There are studies which imply that the AM product monocyte chemoattractant protein-1 (MCP-1) plays an important role. Thus we tested: 1. if the selective elimination of AM attenuates HPH in rats, 2. the correlation of MCP-1 plasmatic concentrations with the presence and absence of AM during exposure to hypoxia, 3. the direct influence of hypoxia on MCP-1 production in isolated AM. We found that experimental depletion of AM attenuated the chronic hypoxia-induced increase in mean pulmonary arterial pressure, but did not affect the serum MCP-1 concentrations. Furthermore, the MCP-1 production by AM in vitro was unaffected by hypoxia. Thus we conclude that AM play a significant role in the mechanism of HPH, but MCP-1 release from these cells is most likely not involved in this process. The increase of MCP-1 accompanying the development of HPH probably originates from other sources than AM | ||
650 | 4 | |a Journal Article | |
650 | 7 | |a Ccl2 protein, rat |2 NLM | |
650 | 7 | |a Chemokine CCL2 |2 NLM | |
650 | 7 | |a Clodronic Acid |2 NLM | |
650 | 7 | |a 0813BZ6866 |2 NLM | |
700 | 1 | |a Vytášek, R |e verfasserin |4 aut | |
700 | 1 | |a Vajnerová, O |e verfasserin |4 aut | |
700 | 1 | |a Hniličková, O |e verfasserin |4 aut | |
700 | 1 | |a Vízek, M |e verfasserin |4 aut | |
700 | 1 | |a Hampl, V |e verfasserin |4 aut | |
700 | 1 | |a Herget, J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Physiological research |d 1996 |g 65(2016), 5 vom: 23. Nov., Seite 763-768 |w (DE-627)NLM012641863 |x 1802-9973 |7 nnns |
773 | 1 | 8 | |g volume:65 |g year:2016 |g number:5 |g day:23 |g month:11 |g pages:763-768 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 65 |j 2016 |e 5 |b 23 |c 11 |h 763-768 |